Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01888302
Title Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mayo Clinic
Indications

cholangiocarcinoma

Therapies

Cisplatin + Gemcitabine + Sirolimus

Age Groups: adult
Covered Countries USA


No variant requirements are available.